| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/13/2002 | EP1185558A1 Peptide having preptin functionality |
| 03/13/2002 | EP1185555A2 Compositions isolated from skin cells and methods for their use |
| 03/13/2002 | EP1185551A1 Method for purification of proteins |
| 03/13/2002 | EP1185549A2 Dna encoding a human subunit of the 5-ht3 serotonin receptor |
| 03/13/2002 | EP1185542A2 Purine derivatives |
| 03/13/2002 | EP1185535A1 Cyclocarbamate and cyclic amide derivatives |
| 03/13/2002 | EP1185532A1 Peroxynitrite decomposition catalysts and methods of use thereof |
| 03/13/2002 | EP1185528A1 Inhibitors of il-12 production |
| 03/13/2002 | EP1185527A1 1-(p-thienylbenzyl)-imidazoles as angiotensin-(1-7) receptor agonists, method for the production and the utilization thereof and pharmaceutical preparations containing said compounds |
| 03/13/2002 | EP1185517A1 Antibiotic prodrugs |
| 03/13/2002 | EP1185516A1 Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect |
| 03/13/2002 | EP1185514A1 Pharmaceutical compositions and methods for use |
| 03/13/2002 | EP1185513A2 Aryl substituted alkylamines capable of activating nicotinic cholinergic receptors |
| 03/13/2002 | EP1185509A2 INHIBITORS OF FACTOR Xa |
| 03/13/2002 | EP1185508A2 Inhibitors of factor xa |
| 03/13/2002 | EP1185304A2 Conjugates comprising cytokines and nucleic acids for treating proliferating cells |
| 03/13/2002 | EP1185302A2 Specifically targeted catalytic antagonists and uses thereof |
| 03/13/2002 | EP1185299A1 Use of antibodies against cd20 for the treatment of the graft versus host disease |
| 03/13/2002 | EP1185296A2 Prevention and treatment of amyloidogenic disease |
| 03/13/2002 | EP1185295A2 Adenosine diphosphatase and activators thereof and their medical uses |
| 03/13/2002 | EP1185294A2 Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders |
| 03/13/2002 | EP1185285A1 49 human secreted proteins |
| 03/13/2002 | EP1185284A1 47 human secreted proteins |
| 03/13/2002 | EP1185277A1 Methods for modulating fxr receptor activity |
| 03/13/2002 | EP1185275A1 Aminopyrimidines as sorbitol dehydrogenase inhibitors |
| 03/13/2002 | EP1185274A1 Drug combinations comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3a4 |
| 03/13/2002 | EP1185271A1 Il-8 receptor antagonists |
| 03/13/2002 | EP1185263A2 Receptor agonists and antagonists |
| 03/13/2002 | EP1185261A1 Il-8 receptor antagonists |
| 03/13/2002 | EP1185247A1 Anti-inflammatory bioactive glass particulates |
| 03/13/2002 | EP1185246A1 Pharmaceutical composition for intranasal use of active substances that are insoluble and/or hardly soluble in water |
| 03/13/2002 | EP1185175A1 Method of increasing the content of flavonoids and phenolic substances in plants |
| 03/13/2002 | EP1185169A2 USE OF TRANSGENIC MICE LACKING JunB EXPRESSION IN THE MYELOID LINEAGE |
| 03/13/2002 | EP1132090A4 Method for producing an agent for treating non-cancerous pathologies of the organism |
| 03/13/2002 | EP1071431A4 Novel delivery of hydroxy carboxylic acids |
| 03/13/2002 | EP0983249B1 Processes and intermediates for preparing substituted indazole derivatives |
| 03/13/2002 | EP0948483B1 Farnesyl transferase inhibitors |
| 03/13/2002 | EP0939639A4 Methods and compositions for reducing or eliminating post-surgical adhesion formation |
| 03/13/2002 | EP0876343B1 Aromatic keto-acids and their derivatives as inhibitors of matrix metalloproteinases |
| 03/13/2002 | EP0841909B1 Use of alicyclic diamines as immunomodulators |
| 03/13/2002 | CN1340103A Complex-forming proteins |
| 03/13/2002 | CN1340098A Astrocytes, their preparation and use thereof |
| 03/13/2002 | CN1340060A Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant |
| 03/13/2002 | CN1340057A Synthetic poly peptide disturbing intracelluler signaling |
| 03/13/2002 | CN1340056A Steroides sulfatase inhibitors and methods for making and using same |
| 03/13/2002 | CN1340055A Shortened-chain polynucleotide and process for the preparation thereof |
| 03/13/2002 | CN1340051A Heteroaryl-substituted quinoline-2-one derivatives useful asticancer agents |
| 03/13/2002 | CN1340049A 4-heterocyclylsulfonamide)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl-or-pyridylpyrimidines as endothelin receptor antagonists |
| 03/13/2002 | CN1340046A β－丙氨酸衍生物 β- alanine derivatives |
| 03/13/2002 | CN1340045A 5-HTIF agonists |
| 03/13/2002 | CN1340044A Nervinolin derivatives |
| 03/13/2002 | CN1339969A Liposone composition and method for administration of a radiosensitizer |
| 03/13/2002 | CN1339965A Combinations of formoterol and fluticasone propionate for asthma |
| 03/13/2002 | CN1339963A Spontaneously dispersible N-benzoyl staurosporine compositions |
| 03/13/2002 | CN1339296A Skin-care rose water |
| 03/13/2002 | CN1080720C 噻唑衍生物 Thiazole derivatives |
| 03/13/2002 | CN1080718C Vitamin D amine and amine derivatives |
| 03/13/2002 | CN1080571C Chinese medicine for treating diseases caused by fatigue |
| 03/13/2002 | CN1080569C Prescription of Yizhifutanwan for reinforcing wisdom and rehabilitating paralysis |
| 03/13/2002 | CN1080567C Kidney-supplementing yang-invigorating channels-freeing dampness-dispelling medicinal liquor |
| 03/12/2002 | US6356845 Crystallization and structure determination of Staphylococcus aureus UDP-N-acetylenolpyruvylglucosamine reductase (S. aureus MurB) |
| 03/12/2002 | US6355805 β3-adrenergic receptor agonists |
| 03/12/2002 | US6355798 Ligands for gamma-aminobutyric acid receptors; anticonvulsants, anxiolytic agents |
| 03/12/2002 | US6355774 Isolated p27 protein |
| 03/12/2002 | US6355695 Antihistamines; asthma therapy |
| 03/12/2002 | US6355690 Remedy for CAG repeat expansion diseases |
| 03/12/2002 | US6355689 Antiinflammatory agents |
| 03/12/2002 | US6355683 Fc receptor modulators and uses thereof |
| 03/12/2002 | US6355680 Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies |
| 03/12/2002 | US6355673 Substituted diaminocarboxylic acids |
| 03/12/2002 | US6355670 Skin disorders |
| 03/12/2002 | US6355662 Peptide and nonpeptides autoimmune diseases, antiinflammatory agents |
| 03/12/2002 | US6355658 Coumarin derivatives, methods of preparation and application as medicines |
| 03/12/2002 | US6355655 Treating a cognitive disorder, a neuro-degenerative disorder; age-related dementia; age-induced memory impairment; a movement disorder, attention deficit disorder; attention deficit hyperactivity disorder; psychosis; cognitive deficits |
| 03/12/2002 | US6355654 Salts of quinoline derivatives as NK3 antagonists |
| 03/12/2002 | US6355653 Amino-triazolopyridine derivatives |
| 03/12/2002 | US6355650 Leukocyte antiadhesion agents |
| 03/12/2002 | US6355648 Thio-oxindole derivatives |
| 03/12/2002 | US6355646 Immunology treatment of inflammatory conditions and immune disorders septic shock |
| 03/12/2002 | US6355632 Naphthyl compounds, intermediates, compositions, and methods |
| 03/12/2002 | US6355618 Enzyme inhibitors |
| 03/12/2002 | US6355614 Drugs of cyclic boroproline with carriers |
| 03/12/2002 | US6355613 Cyclized oligopeptides with bridging groups of amide, thioether, thioester or disulfide |
| 03/12/2002 | US6355483 Antisense nucleotides for use in the treatment of leukemia |
| 03/12/2002 | US6355480 Nucleotide sequences which code preferential protein for use in the treatment of fertility and cell proliferation defects |
| 03/12/2002 | US6355460 Detecting enzyme inhibitors; incubate enzyme with modulator, monitor sample for reduction in enzyme activity, reduction in enzyme activity indicates modulator |
| 03/12/2002 | US6355440 Detecting cell growth factors in sample; mix target sample with preferential receptors, detect binding, bound receptor indicates presence of cell growth factor in sample |
| 03/12/2002 | US6355270 Particles for oral delivery of peptides and proteins |
| 03/12/2002 | US6355268 Liposome-entrapped topoisomerase inhibitors |
| 03/12/2002 | US6355265 Over-coated chewing gum formulations |
| 03/12/2002 | US6355258 Method for formulating spill resistant pharmaceutical compositions in semi-solid form |
| 03/12/2002 | US6355241 In vivo production and delivery of erythropoietin |
| 03/12/2002 | US6355239 Uses for non-autologous mesenchymal stem cells |
| 03/12/2002 | CA2313783C Pharmaceutical compositions of (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3r,5s)-3,5-dihydroxyhept-6-enoic acid or a salt thereof |
| 03/12/2002 | CA2235625C Bactericidal/permeability increasing protein (bpi) for treating conditions associated with corneal transplantation |
| 03/12/2002 | CA2137889C Eburnan analogs; process for preparing the same and pharmaceutical compositions containing them |
| 03/12/2002 | CA2064077C T cell receptor peptides as therapeutics for autoimmune and malignant disease |
| 03/12/2002 | CA2055947C Condensed heterocyclic compounds, their production and use |
| 03/07/2002 | WO2002019213A2 Method for treatment of migraine using pde5 inhibitors |
| 03/07/2002 | WO2002018623A2 Methods and reagents for protease inhibition |